Davis Jennifer L. 4
4 · AbbVie Inc. · Filed May 12, 2026
Research Summary
AI-generated summary of this filing
AbbVie (ABBV) Director Jennifer L. Davis Receives RSU Award
What Happened
- Jennifer L. Davis, a director of AbbVie Inc., was granted 1,118 restricted stock units (RSUs) on 2026-05-08. The filing reports an acquisition at $0.00 per unit (award), so there was no cash exchanged at grant. This is a compensation award (transaction code A), not a market purchase or sale.
Key Details
- Transaction date: 2026-05-08; Filing date (Form 4): 2026-05-12 (appears timely; within the 2-business-day filing window).
- Number of units awarded: 1,118 RSUs; reported price: $0.00; immediate cash value: $0 (units convert to shares later).
- Shares owned after transaction: not specified in the provided filing details.
- Footnote: RSUs were awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program and will be paid one-for-one in AbbVie common stock on the earlier of the director’s separation from service, death, or a change in control.
Context
- RSUs are deferred equity awards that do not represent current tradable shares until they vest/are settled; they are commonly used for director compensation and do not by themselves indicate a buy/sell sentiment.
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Davis Jennifer L.
Director
Transactions
- Award
Common Stock, $0.01 par value
[F1]2026-05-08+1,118→ 3,643 total
Footnotes (1)
- [F1]These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Jennifer L. Davis|2026-05-12